Protagenic Therapeutics Stock Technical Analysis

PTIX Stock  USD 0.26  0.02  8.33%   
As of the 27th of February, Protagenic Therapeutics holds the Coefficient Of Variation of (949.13), risk adjusted performance of (0.07), and Variance of 67.09. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protagenic Therapeutics, as well as the relationship between them.

Protagenic Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Protagenic, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Protagenic
  
Protagenic Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Protagenic Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
4.0Buy1Odds
Protagenic Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Protagenic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Protagenic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Protagenic Therapeutics, talking to its executives and customers, or listening to Protagenic conference calls.
Protagenic Analyst Advice Details
Protagenic Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Protagenic Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Protagenic Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Protagenic Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Protagenic Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Protagenic Therapeutics Trend Analysis

Use this graph to draw trend lines for Protagenic Therapeutics. You can use it to identify possible trend reversals for Protagenic Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Protagenic Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Protagenic Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Protagenic Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.0062  , which may suggest that Protagenic Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.47, which is the sum of squared deviations for the predicted Protagenic Therapeutics price change compared to its average price change.

About Protagenic Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Protagenic Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Protagenic Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Protagenic Therapeutics price pattern first instead of the macroeconomic environment surrounding Protagenic Therapeutics. By analyzing Protagenic Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Protagenic Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Protagenic Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2024 2025 (projected)
Payables Turnover0.290.27
Days Of Inventory On Hand269.53275.1

Protagenic Therapeutics February 27, 2025 Technical Indicators

Most technical analysis of Protagenic help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Protagenic from various momentum indicators to cycle indicators. When you analyze Protagenic charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Protagenic Therapeutics February 27, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Protagenic stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.